FGD5 and gastric cancer: These findings are very encouraging, as it indicates that FGD5-AS1 may potentially serve as a prognostic biomarker for patients with gastric cancer, despite the heterogeneous nature of gastric tumorigenesis, development, and metastasis (Nadauld and Ford, 2013; Hudler, 2015).